Section Arrow
RNLX.NASDAQ
- Renalytix plc
(Financial Status)
Quotes are at least 15-min delayed:2024/06/25 02:28 EDT
Last
 0.4571
+0.0049 (+1.08%)
Day High 
0.4649 
Prev. Close
0.4522 
1-M High
0.5933 
Volume 
59.09K 
Bid
0.4581
Ask
0.4624
Day Low
0.4501 
Open
0.4536 
1-M Low
0.3497 
Market Cap 
34.90M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.47 
20-SMA 0.45 
50-SMA 0.59 
52-W High 4.0377 
52-W Low 0.2449 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.76/-0.68
Enterprise Value
42.43M
Balance Sheet
Book Value Per Share
-0.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.40M
Operating Revenue Per Share
0.04
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SHCRSharecare1.375+0.005+0.36%-- 
TDOCTeladoc Health10.36+0.65+6.69%-- 
MPLNMultiPlan Corp0.3684+0.0019+0.52%-- 
SOLVSolventum Corp51.3-1.05-2.01%14.23PE
GEHCGE HealthCare Technologies78.85-0.32-0.40%23.01PE
Quotes are at least 15-min delayed:2024/06/25 02:28 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.